PTS Diagnostics Named to Inc. Magazine's 2015 List of the 5,000 Fastest Growing Private Companies

PTS Diagnostics Named to Inc. Magazine’s 2015 List of the 5,000 Fastest Growing Private Companies

Global medical device manufacturer selected for fifth time to prestigious list based on three-year sales growth of 137%

Indianapolis, IN – August 17, 2015 – PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, was ranked as one of the nation’s fastest-growing private companies by Inc. magazine. The magazine’s 34th annual “Inc. 5000 list” ranked PTS Diagnostics as the 2,684th fastest growing company in the United States.

Last year, PTS Diagnostics earned its place on the list with 80 percent growth over the previous three years. PTS Diagnostics continued to increase sales by earning 137 percent growth over the past three years in the 2015 list.

“Our fast, easy, portable and accurate point-of-care diagnostic devices test people around the world for multiple key disease states, including high cholesterol and diabetes, with just a simple fingerstick,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “We have also just expanded our portfolio of products to include the PTS Detect tobacco-detection system, the only point-of-care device that offers quantitative results from a fingerstick.”

In addition, the company recently launched the PTS Pod collection system further innovating its line of point-of-care testing options. To complement its line of diagnostic devices, in early 2015 the company introduced PTS Diagnostics capillary tubes, and the PTS Connect wellness solution, an online information management and patient communication software tool.

Founded in 1992, PTS Diagnostics was specially recognized by Inc. Magazine as a Five-Time Inc. 5000 Honoree. The company earned its spot on the list with rankings in 2007, 2008, 2013, 2014 and now 2015.

“As we continue to grow our business in the US and around the globe, we are pleased that our devices will test upwards of 25 million people this year,” said Huffstodt. “Our nearly 180 employees work hard to continue our ongoing commitment to provide a full suite of world-class point-of-care diagnostic solutions to healthcare professionals of all kinds, all around the world.”

The Inc. 5000 profiles are available on

“The story of this year’s Inc. 5000 is the story of great leadership. In an incredibly competitive business landscape, it takes something extraordinary to take your company to the top,” said Inc. President and Editor-In-Chief Eric Schurenberg.

Huffstodt concluded, “It’s gratifying for all of us to see our growth strategies validated in the marketplace and recognized by the media. Our goal is for a repeat performance in 2016.”

About PTS Diagnostics
PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service.

PTS Diagnostics’ signature products include the CardioChek® lipid analyzer and the A1CNow® family of products. The CardioChek® family of products have screened more than 120 million patients worldwide while the A1CNow® product line works to enable people to lead healthier lives through ongoing management of diabetes. Together these products help identify individuals with cardiometabolic syndrome, a cluster of conditions that increase risks of developing cardiovascular disease or diabetes.

Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. More information is available at .

For more information, visit or contact Tom Wiser at 317-870-5610.

SOURCE: PTS Diagnostics

MKG001660 Rev. 0 8/15